Other
Vaping
Vaping is an intervention with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Terminated(2)
Detailed Status
Recruiting2
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
terminated125%
withdrawn125%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
terminatednot_applicable
Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography
NCT05876091
recruitingnot_applicable
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
NCT06260683
recruiting
Vaping Adverse Lung and Heart Events Cohort
NCT06291597
withdrawn
Vaping-Related Seizures - A Prospective Study
NCT06006442
Clinical Trials (4)
Showing 4 of 4 trials
NCT05876091Not Applicable
Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography
NCT06260683Not Applicable
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
NCT06291597
Vaping Adverse Lung and Heart Events Cohort
NCT06006442
Vaping-Related Seizures - A Prospective Study
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4